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The aim of this study was to analyze motor unit reorganization in different types of
progressive muscular dystrophies and congenital myopathies.
The study population consisted of patients with genetically veriﬁed progressive muscu-
lar dystrophies: Duchenne (DMD) (n = 54), Becker (BMD) (n = 30), facio-scapulo-humeral
(FSHD) (n = 37), and Emery–Dreifuss (E-DD) (n = 26). Patients with probable limb-girdle
dystrophy (L-GD) (n = 58) and congenital myopathies (n = 35) were also included in the study.
Quantitative EMG recordings were obtained from 469 muscles. Muscle activity at rest and
during slight voluntary and maximal muscle contraction was analyzed. The motor unit
activity potential (MUAP) duration, amplitude, area, size index (SI), polyphasicity, and the
presence of ‘‘outliers’’ were evaluated.
Diminished values of MUAP parameters and decreased maximal amplitude of maximal
muscle contraction were recorded most frequently in DMD and mainly in the biceps brachii
muscles. SI was the most frequently changed EMG parameter. ‘‘Outliers’’ with amplitude
below the normal range were recorded more frequently then a decreased mean MUAP
amplitude (what could indicate a very high sensitivity of this EMG parameter). Pathological
interference pattern was recorded in 34.7% of biceps brachii and in 21.2% of rectus femoris
muscles. In FSHD, decreased MUAP duration and SI and pathological interference pattern
with low amplitude were recorded most frequently in the tibial anterior and deltoid muscles.
The presence of potentials with reduced parameters is a result of decreasing motor unit
area (reduced number and size of muscle ﬁbers), while high amplitude potentials recorded in
BMD and E-DD could indicate a slow and mild course of disease and muscle regeneration.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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1.1. Progressive muscular dystrophies
Progressive muscular dystrophies (PMD) are a group of
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proteins (emerin, lamin A/C). Common features of protein
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their phenotypes are also observed [1–9].
1.2. Diagnosis of progressive muscular dystrophies
Genetic testing is considered the only reliable diagnostic
criterion in neuromuscular disorders but this method is rarely
the ﬁrst line of laboratory tests and needs guidance from other
methods. Electrophysiological tests could be the ﬁrst key tool
for the diagnosis of primary muscle diseases, especially in
limb-girdle dystrophy, and they remain very important in the
evaluation of disease progression and muscle dysfunction [10–
13].
1.3. Electromyography in progressive muscular
dystrophies
By EMG, the criteria for myopathy in primary muscle diseases
are most commonly fulﬁlled as decreased values of single
motor unit action potentials (MUAPs), an increased percentage
of polyphasic potentials, and a pathological interference
pattern at maximal muscle activation [14–21]. In addition to
short and low MUAPs, characteristic for myopathy, potentials
with an increased amplitude and prolonged duration are also
observed and their origin has not been sufﬁciently explained
yet. Contribution of a neurogenic factor to reorganization of a
myopathic motor unit has been discussed in the literature
[16,22–25].
1.4. Aims of the study
The aims of the study were:
- to analyze EMG recordings obtained in progressive muscular
dystrophies (PMD), including Duchenne (DMD), Becker
(BMD), limb-girdle (L-GD), facio-scapulo-humeral (FSHD),
and Emery–Dreifuss (E-DD) types, and in congenital myopa-
thies (CM);
- to compare EMG data in two dystrophinopathies, quickly
progressing DMD and a more benign, slowly progressing
BMD;
- to compare EMG data in a dystrophinopathy (BMD) and in a
nucleopathy (E-DD), both with a slow course of disease and
different localization of muscle structural lesions.Table 1 – Characteristics of patients.
Diagnosis Sex Age years (range)
M F 
Duchenne muscular dystrophy 54 6  2 (4–15) 
Becker muscular dystrophy 30 13  6 (3–24) 
Fascio-scapulo-humeral dystrophy 23 14 28  16 
Emmery–Dreifuss dystrophy 26 18  6 
Limb-girdle dystrophy 31 27 19  11 (12–57) 
Congenital myopathies 22 13 14  11 
Overall 186 54 17.5 2. Material and methods
2.1. Characteristics of patients
Two hundred and forty patients (186 M; 54 F, mean age 17.5
years) were recruited to the study at the Department of
Neurology, Medical University of Warsaw, and a written
informed consent was provided by all participants.
The study population consisted of genetically veriﬁed
patients with four progressive muscular dystrophies: DMD,
BMD, FSHD, and E-DD. In addition, patients with probable L-GD
and with CM after combining clinical status data and biopsy
ﬁndings were included in the study group (Table 1).
2.2. EMG studies
Electromyographic (EMG) recordings were obtained from 469
muscles (186 biceps brachii (BB), 219 rectus femoris (RF), and
additionally in the FSHD group also 34 tibial anterior (TA), and
30 deltoid (DD) muscles) (Table 1).
Strength of the examined muscles was assessed using the
MRC scale (0–5, with 0 indicating no action, and 5 indicating
normal muscle strength), and muscle atrophy was assessed
using a 0–3 scale (0 – no atrophy, 3 – marked atrophy).
Muscle activity was recorded during routine EMG examina-
tions using a concentric needle electrode (DCN37 type) with
0.07 mm2 uptake area, 0.46 mm diameter and 37 mm length.
The Keypoint system (Medtronic) was used to evaluate EMG
recordings. EMG recordings were registered at muscle rest and
during slight voluntary (according to the multi-MUAP method)
and maximal muscle contractions.
At rest, spontaneous activity was analyzed, including
pseudomyotonic discharges, positive sharp waves, and ﬁbril-
lations.
During voluntary muscle contraction (10–20% of maximal
muscle contraction), automatic quantitative evaluation of
single motor unit potentials (MUAPs) was performed, and the
evaluated parameters included duration, amplitude, area, size
index (SI), and polyphasicity [26–28]. The mean values of these
parameters and the number of outliers (minimum 3 single
MUAPs) out of the normal range were calculated [29]. Mean
results were compared to the reference values according to
Bischoff and Stålberg [30,31] used in our laboratory. The mean Number of muscles
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Fig. 2 – Abnormal mean MUAP duration in PMD and CM (%
of muscles).
# – MUAP duration below the normal range.
" – MUAP duration above the normal range.
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recorded MUAPs.
At maximal effort, amplitude was measured and the
density of the interference pattern was estimated using visual
assessment.
In addition to molecular tests muscle biopsies were
performed in most of the patients with PMD (and in all
patients with E-DD and CM).
2.3. Statistical methods
EMG results were analyzed using the following statistical
methods: Student t-test, Wilcoxon, Shapiro–Wilk, Duncan,
Kruskal–Wallis and Fisher tests, and the GLIMMIX procedure
(logistic regression model). Analyses were performed using the
SAS software, version 9.2. Statistical signiﬁcance was set at
P < 0.05 [32,33].
3. Results
Evaluation of conduction velocity parameters in the peripheral
nerves of upper and lower limbs did not reveal any
abnormalities in the whole group of patients except for one
FSHD case in whom carpal tunnel syndrome was diagnosed.
In the whole examined group, typical myopathic recordings
such as reduced values of MUAP parameters values and a
pathological interference pattern were recorded more fre-
quently in BB comparing to RF muscles (outliers with a
decreased amplitude were recorded in 61.9% of BB and in 25.9%
of RF muscles).
A reduced mean SI value was recorded in more than 50% of
BB and RF muscles, most frequently in the E-DD group (in
88.9% of RF muscles) (Fig. 1).
A reduced mean SI value in both BB and RF muscles in the
same patient was noted in 33.6% of cases; most frequently in
the DMD group (in 55% of patients). An increased mean SI
value was recorded in 5% of all examined muscles.59,3
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Fig. 1 – Abnormal mean MUAP size index (SI) values in PMD
and CM (% of muscles).
# – SI below the normal range.
" – SI above the normal range.
Fig. 3 – Abnormal mean MUAP amplitude in PMD and CM (%
of muscles).
# – MUAP amplitude below the normal range.
" – MUAP amplitude above the normal range.In the whole examined group, a reduced mean MUAP
duration was recorded in 45.5% of BB and in 37.2% of RF
muscles, most frequently in the DMD group (in 58.3% of BB
muscles) (Fig. 2).
MUAPs with an increased mean duration and outliers with
prolonged duration were observed in a few percent of all
examined muscles.
A reduced mean MUAP amplitude was noted in 17% of BB
and in 14.5% of RF muscles, most frequently in the CM group
(in 50% of RF and in 32.1% of BB muscles, respectively) (Fig. 3).
Outliers with a reduced amplitude were observed twice more
frequently in BB comparing to RF muscles, most frequently in
the DMD group (in 82.8% of BB and in 49.1% of RF muscles,
respectively) (Fig. 4).
An increased mean MUAP amplitude was recorded in a few
percent of all examined patients, and in no cases of DMD and
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Fig. 4 – Outliers with amplitude out of the normal range in
PMD and CM (% of muscles).
# – Amplitude below the normal range.
" – Amplitude above the normal range.
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Fig. 5 – Polyphasicity in PMD and CM (% of muscles).
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Fig. 6 – Pathological interference pattern during maximal
muscle contraction in PMD and CM (% of muscles).
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Fig. 7 – Amplitude of the interference pattern (range 0.1–
0.5 mV) in PMD and CM (% of muscles).
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Fig. 8 – Acute denervation in PMD and CM (% of muscles).
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range were observed most frequently in E-DD and BMD
patients (in 15.3% and 11.1% of BB muscles, respectively),
and in no cases of DMD (Figs. 3 and 4).
In the whole examined group, an increased percentage of
polyphasic potentials was recorded most frequently in E-DD
patients (in 57.7% of BB muscles) (Fig. 5).
A pathological interference pattern during maximal muscle
contraction was recorded in 34.7% of BB and 21.2% in RF
muscles (Fig. 6).
A very low amplitude of the interference pattern (in the
range of 0.1–0.5 mV) was observed most frequently in the DMD
group (in 66.6% of BB and 78.5% of RF muscles, respectively)
(Fig. 7).
In patients with FSHD, decreased mean MUAP duration,
and SI were recorded more frequently in TA and DD muscles
compared to BB and RF muscles (in 72.4% and 68.9% of TA
muscles and in 55.8% and 50% of DD muscles, respectively).
Mean values of MUAP parameters recorded in TA muscles
differed signiﬁcantly (P < 0.05) from the same parameters
recorded in BB, DD and RF muscles.
Spontaneous activity was registered in a similar percentage
of BB and RF muscles, most frequently in DMD and E-DDpatients (in 34% of RF and 29.1% of BB muscles, respectively)
(Fig. 8).
Logistic regression models (GLIMMIX procedure) showed
that EMG results differed most between the DMD and E-DD
groups.
The Fisher, Wilcoxon and Kruskal–Wallis tests showed a
signiﬁcantly higher frequency of decreased mean SI values
and MUAP duration in DMD compared to BMD patients
(P < 0.0001 and P > 0.004, respectively). A reduced mean
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 2 2 3 – 2 2 8 227amplitude and outliers with a reduced amplitude in BB and RF
muscles were also observed more frequently in the DMD group
than in the BMD group.
Comparison between the BMD and E-DD groups revealed a
similar percentage (40%) of BB and RF muscles with a
decreased mean MUAP duration, while outliers with a short
duration in these two examined muscles were noted several
times more frequently in the E-DD group compared to the BMD
group (in 11.35% of BB muscles and 3.4% of RF muscles in BMD
patients, and in 22.8% of BB muscles and 31.3% of RF muscles in
E-DD patients, respectively). A reduced mean SI was observed
more frequently in the E-DD group compared to the BMD group
(88.9% and 55.1% of RF muscles, respectively). A reduced mean
MUAP amplitude was observed in 10% of BB muscles in the
BMD and E-DD groups, while an increased mean MUAP
amplitude was observed in only 7.7% of BB muscles in the
E-DD group.
A very low amplitude of maximal muscle effort (range 0.1–
0.5 mV) was recorded signiﬁcantly more frequently in the DMD
group compared to the BMD group, and in the BMD group
compared to the E-DD group (Fig. 7).
4. Discussion
Genetic tests are crucial for the diagnosis of congenital
primary muscle diseases but EMG studies also remain very
important. Features of a muscle potential such as its size and
shape reﬂect the activity of the progression of muscle
structure pathology [14,34,35].
Our EMG data obtained in PMD and CM generally fulﬁlled
the criteria of a primary muscle lesion [15,17,20]. The most
frequently changed EMG parameter was SI, estimating
motor unit size, and a decreased mean SI value was
recorded in more than 50% of BB and RF muscles. A reduced
mean MUAP amplitude was observed in several percent of
BB and RF muscles in the whole examined group, while
‘‘outliers’’ with an amplitude below the normal range were
recorded in 61.9% of BB and 25.9% of RF muscles (in DMD in
as many as 82% of BB muscles). In our opinion, these
ﬁndings indicate a clear value of outliers, mainly in the ﬁrst
stage of the muscle disease when damage to the muscle
structure is mild and limited.
Typical myopathic EMG recordings in PMD and CM were
recorded more frequently in BB then in RF muscles. In the
FSHD group, reduced mean MUAP duration, decreased SI, and
the presence of a pathological interference pattern with a low
amplitude were obtained most frequently in DD and TA
muscles. These ﬁndings revealed that TA and DD muscles are
more sensitive for muscle abnormalities, and thus they should
be examined in all cases of suspected FSHD.
Decreased values of single potential parameters and a
reduced amplitude of maximal effort were present more often
in DMD compared to BMD, probably as a result of more acute
and severe muscle structural damage, seen in muscle biopsy
as a global reduction of muscle ﬁber number and diameter. In
DMD, decreased membrane potential of persistent muscle
ﬁbers and a frequent absence of the initial and terminal phase
of the potential cause shortening of MUAP duration and result
in low values of MUAP amplitude.A slow and mild course of BMD allows activation of muscle
regeneration which is observed in EMG as the presence of
single potentials with a high amplitude.
MUAPs with an increased mean amplitude and outliers
with the amplitude above the normal range were recorded also
in E-DD (nucleopathy). These high potentials, noted more
frequently in E-DD than in BMD, are probably a result of the
presence of multiple hypertrophic muscle ﬁbers, their split-
ting, and in E-DD also due to a selective reduction in small-
diameter type 1 muscle ﬁbers. No typical features of
neurogenic muscle lesion were observed in muscle biopsy
performed in our patients with E-DD and BMD.
5. Conclusions
In summary, EMG recordings obtained in progressive muscu-
lar dystrophies and congenital myopathies revealed mostly
typical myopathic changes, with the biceps brachii seemingly
a more sensitive muscle for myopathic abnormalities. It was
also conﬁrmed that in FSHD, the obligatory muscles for EMG
examinations are deltoid and tibial anterior muscles. De-
creased values of MUAP parameters found more frequently in
DMD compared to BMD conﬁrmed a more active progression of
the former.
Our analyses suggest that high amplitude MUAPs which are
noted more frequently in E-DD and BMD could be a result of a
chronic myopathic process with hypertrophy and splitting of
muscle ﬁbers. In addition, our study indicates a clear value of
outliers, mainly in the ﬁrst stage of muscle disease.
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